Johannes Gutenberg University of Mainz-ko ikertzaileekin lankidetzan egindako argitalpenak (45)

2024

  1. Survival in primary hemophagocytic lymphohistiocytosis, 2016 to 2021: etoposide is better than its reputation

    Blood, Vol. 143, Núm. 10, pp. 872-881

2023

  1. Allogeneic hematopoietic stem cell transplantation for NK/T-cell lymphoma: an international collaborative analysis

    Leukemia, Vol. 37, Núm. 7, pp. 1511-1520

  2. Risk factors for recurrence and major bleeding in patients with cancer-associated venous thromboembolism

    European Journal of Internal Medicine, Vol. 112, pp. 29-36

2021

  1. Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition)1

    Autophagy, Vol. 17, Núm. 1, pp. 1-382

  2. Preoperative nasopharyngeal swab testing and postoperative pulmonary complications in patients undergoing elective surgery during the SARS-CoV-2 pandemic

    British Journal of Surgery, Vol. 108, Núm. 1, pp. 88-96

2020

  1. A european study of the performance and safety of MINIject in patients with medically uncontrolled open-angle glaucoma (STAR-II)

    Journal of Glaucoma, Vol. 29, Núm. 10, pp. 864-871

  2. Apixaban for the treatment of venous thromboembolism associated with cancer

    New England Journal of Medicine, Vol. 382, Núm. 17, pp. 1599-1607

  3. Bioresorbable vascular scaffold versus metallic drug-eluting stent in patients at high risk of restenosis: The COMPAREABSORB randomised clinical trial

    EuroIntervention, Vol. 16, Núm. 8, pp. 645-653

  4. Tetraspanin CD9 affects HPV16 infection by modulating ADAM17 activity and the ERK signalling pathway

    Medical Microbiology and Immunology, Vol. 209, Núm. 4, pp. 461-471

2019

  1. Ibrutinib for the treatment of relapsed/refractory mantle cell lymphoma: Extended 3.5-year follow up from a pooled analysis

    Haematologica

  2. Influence of antisynthetase antibodies specificities on antisynthetase syndrome clinical spectrum time course

    Journal of Clinical Medicine, Vol. 8, Núm. 11

  3. Three-Year Results of Hydrus Microstent with Phacoemulsification

    Ophthalmology. Glaucoma, Vol. 2, Núm. 6, pp. 440-442

2018

  1. Timing of onset affects arthritis presentation pattern in antisynthetase syndrome

    Clinical and Experimental Rheumatology, Vol. 36, Núm. 1, pp. 44-49

2017

  1. Clinical follow-up predictors of disease pattern change in anti-Jo1 positive anti-synthetase syndrome: Results from a multicenter, international and retrospective study

    Autoimmunity Reviews, Vol. 16, Núm. 3, pp. 253-257

2016

  1. 24-h Efficacy of Glaucoma Treatment Options

    Advances in Therapy, Vol. 33, Núm. 4, pp. 481-517

  2. Analysis of plasminogen genetic variants in multiple sclerosis patients

    G3: Genes, Genomes, Genetics, Vol. 6, Núm. 7, pp. 2073-2079

  3. Erratum to: 24-h Efficacy of Glaucoma Treatment Options (Adv Ther, 10.1007/s12325-016-0302-0)

    Advances in Therapy

  4. Erratum to: Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition) (Autophagy, 12, 1, 1-222, 10.1080/15548627.2015.1100356

    Autophagy

  5. Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition)

    Autophagy, Vol. 12, Núm. 1, pp. 1-222

  6. Liver Retransplantation in Patients with HIV-1 Infection: An International Multicenter Cohort Study

    American Journal of Transplantation, Vol. 16, Núm. 2, pp. 679-687